Comparison of Systemic and Intrarenal Converting Enzyme Inhibition by MK-422 on Renal Hemodynamics in Conscious Dogs
Authors:
- Ben G. ZimmermanBZBen G. Zimmerman
- Caria J. FinisCFCaria J. Finis
- 1 July 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 7 (4) , 715-722
Abstract
The purpose of this study was to compare the effect of intrarenal angiotensin converting enzyme (ACE) inhibition with that of systemic ACE inhibition in conscious, instrumented dogs. Intrarenal ACE inhibition was achieved by infusing the potent ACE inhibitor MK-422 into the renal artery in a dose (0.32 micrograms/kg/min) that in dogs fed a normal sodium (n = 11) and low sodium (n = 10) diet markedly attenuated the renal blood flow response to intrarenal arterial angiotensin I (0.4 and 0.8 micrograms, respectively). Intrarenal arterial infusion of MK-422 decreased the responses by 76 and 72% in the normal and low sodium groups, respectively, but only decreased renal vascular resistance slightly (-9 and -8%, respectively) in the infused kidney. Following termination of intrarenal arterial infusion of MK-422, the inhibitor was administered intravenously, 0.2 mg/kg. This dose of MK-422 maximally inhibited systemic ACE, as evidenced by the complete abolition of the renal blood flow response to intravenous angiotensin I; the responses were decreased by 95 and 96% in the normal and low sodium groups, respectively. In contrast to the negligible reduction in renal vascular resistance seen during intrarenal arterial infusion of MK-422, systemically administered inhibitor decreased renal vascular resistance by 16 and 39%, respectively, in the normal and low sodium groups. These results lend additional support to our contention that systemically rather than intrarenally formed angiotensin II is mainly responsible for regulation of renal vascular resistance.Keywords
This publication has 15 references indexed in Scilit:
- Renal blood flow changes in contralateral kidney of Goldblatt hypertensive dogAmerican Journal of Physiology-Heart and Circulatory Physiology, 1981
- Renal Vasodilator Responses to Captopril in Dogs Pretreated with IndomethacinExperimental Biology and Medicine, 1981
- Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.The Journal of Pharmacology and Experimental Therapeutics, 1981
- Demonstration of a Primary Antidiuretic Action of Angiotensin II: Effects of Intrarenal Converting Enzyme Inhibition in the Conscious Dog*Endocrinology, 1981
- Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.The Journal of Pharmacology and Experimental Therapeutics, 1980
- Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captoprilLife Sciences, 1980
- Sympathetic nerve function and renal hemodynamics during hemorrhage: role of pre- and postsynaptic interactions between angiotensin II and prostaglandins.The Journal of Pharmacology and Experimental Therapeutics, 1979
- Effect of exogenous and endogenous angiotensin II in the isolated perfused rat kidneyAmerican Journal of Physiology-Renal Physiology, 1978
- Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.Circulation Research, 1977
- Renal hemodynamicsThe American Journal of Medicine, 1964